Neil McLoughlin
General Counsel bei DATALEX PLC
Vermögen: 84 488 $ am 31.03.2024
Profil
Neil McLoughlin is currently working as the Secretary, Chief Commercial & Legal Officer at Datalex Plc.
Previously, he worked as the Associate General Counsel at Elan Corp.
Plc.
He also served as the Chief Operating Officer at Malin Corp.
Plc from 2015 to 2018.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
DATALEX PLC
0,12% | 31.12.2022 | 159 653 ( 0,12% ) | 84 488 $ | 31.03.2024 |
Aktive Positionen von Neil McLoughlin
Unternehmen | Position | Beginn |
---|---|---|
DATALEX PLC | General Counsel | 23.08.2019 |
Ehemalige bekannte Positionen von Neil McLoughlin
Unternehmen | Position | Ende |
---|---|---|
MALIN CORPORATION PLC | Chief Operating Officer | 01.11.2018 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
DATALEX PLC | Technology Services |
MALIN CORPORATION PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |